Recida Therapeutics, Inc.

Biotechnology company · Menlo Park, California, United States

Recida Therapeutics, Inc. is a biotechnology company headquartered in Menlo Park, California, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $5.7 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Recida Therapeutics at a glance

Typebiotechnology company
HeadquartersMenlo Park, California, United States
Earliest incorporation on record2016
SEC CIK1746104

What does Recida Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $5.7 million sold (2018).

Frequently asked questions about Recida Therapeutics

Where is Recida Therapeutics headquartered?

Recida Therapeutics, Inc. is headquartered in Menlo Park, California, United States.

What does Recida Therapeutics do?

Recida Therapeutics, Inc. is a biotechnology company.

When was Recida Therapeutics founded?

The earliest incorporation on record for Recida Therapeutics, Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences